Mithra Pharmaceuticals SA Company
Mithra Pharmaceuticals was founded by entrepreneur François Fornieri and Prof. Dr. Foidart, as a spin-off of the University of Liège in 1999. Mithra is dedicated to providing innovation and choice in women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop new and improved products that meet women’s needs for better safety and convenience. Its two lead development candidates – a fifth-generation oral contraceptive, Estelle®, and a next-generation hormone therapy, Donesta® – are built on Mithra’s unique natural estrogen platform, E4 (Estetrol). Mithra also develops, manufactures and markets complex therapeutics and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO.